Monday, May 15, 2023 8:54:24 PM
The dilution for each quarter of 2021 is below. Keep in mind that the dilution earlier in2021 was at a much higher price than by the end of the year. Right at one billion new shares dumped in Q3 and Q4 while they claim that it would end soon. People made trading decisions based on information like that.
FAQ Page released July 2021
https://ethema.wpengine.com/?page_id=683
When will the debt be brought under control and when will the dilution stop?
...We cannot tell yet how much more conversion there will be but the rate and amount are in a dramatic decline. We do see an end coming soon since that has been the direction for much of the past three months...
Ethema has added an FAQ section to its website https://t.co/L97AvfEQy0 and has established a forum for frequently asked shareholder questions. $GRST
— Ethema Health (@HealthEthema) July 27, 2021
For the quarterly period ended March 31, 2021
https://www.otcmarkets.com/filing/html?id=14979734&guid=Qum-kp5mwFwMgrh
Authorized and outstanding
The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 2,262,849,130 and 2,027,085,665 shares of common stock at March 31, 2021 and December 31, 2020, respectively
235,763,465 new shares for Q1 2021
For the quarterly period ended June 30, 2021
https://www.otcmarkets.com/filing/html?id=15181522&guid=Qum-kp5mwFwMgrh
Authorized and outstanding
The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 2,601,515,456 and 2,027,085,665 shares of common stock at June 30, 2021 and December 31, 2020, respectively. 338,666,326 shares for Q2
338, 666,326 increase for period Q2 2021
For the quarterly period ended September 30, 2021
https://www.otcmarkets.com/filing/html?id=15373092&guid=Qum-kp5mwFwMgrh
Authorized and outstanding
The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 3,111,047,811 and 2,027,085,665 shares of common stock at September 30, 2021 and December 31, 2020, respectively.
509,532,355 new shares for Q3 2021
For the fiscal year ended: December 31, 2021
https://www.otcmarkets.com/filing/html?id=15732252&guid=Qum-kp5mwFwMgrh
a) Common shares
Authorized and outstanding
The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 3,579,053,805 and 2,027,085,665 shares of common stock at December 31, 2021 and December 31, 2020, respectively.
468,005,994 new shares for Q4 2021
Everything that I post is just my informed opinion and is simply an invitation to debate. Trade on your own due diligence please..
Recent GRST News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 08:46:15 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 07:23:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/29/2024 05:40:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/29/2024 05:39:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 09:25:38 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 06/11/2024 06:20:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 02:47:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/31/2024 08:27:28 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/07/2024 08:16:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:45:09 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/22/2023 09:04:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:55:26 PM
- Form 1-A POS - • Edgar (US Regulatory) • 10/20/2023 07:29:40 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM